We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Aging Committee Releases Internal Valeant Documents
Several days after Valeant Pharmaceuticals International executives pledged to establish a committee to review its drug pricing practices, the Senate Aging Committee released a treasure trove of documents related to the company’s internal pricing strategies.